Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
PubMed 5
[PubMed | ClinicalTrials.gov | DOI] Garvey WT, Batterham RL, Bhatt DL, et al
Product Features 5mg BPC-157 peptide per vial Lyophilised powder format Research grade material Sealed laboratory vial Tamper evident cap Individually batch coded For laboratory research use only Product Specification Storage Instructions Store refrigerated between 2C and 8C Keep vial sealed until use Protect from heat, moisture, and direct sunlight Handle only within suitable laboratory conditions Important Notice This product is supplied strictly for laboratory research and analytical purposes only
I wish it was more portable thank you Verified review - view original Good price for a great product
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
US$ 21.42
US$ 22.02
US$ 28.87
